The best-studied candidate gene for neurodegeneration in MS is APOE (apoliporotein E) with its ε4 allele conferring increased risk for AD, but the role of the APOE locus in MS remains unclear [10], [11], [12]. This evidence concerns the gene APOE and myeloid sarcoma.